COVID-19 Impact on Global Orthostatic Hypotension Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: CBD0F9EE066EEN
QYResearch

Abstracts

This report focuses on the global Orthostatic Hypotension Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthostatic Hypotension Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Amneal Pharmaceuticals Inc.
• H. Lundbeck AS
• Mylan NV
• Novartis AG
• Pfizer Inc.
• ...

Market segment by Type, the product can be split into

• Midodrine
• Northera (droxidopa)
• Fludrocortisone
• Other Drugs

Market segment by Application, split into

• Hospital
• Medical Research Institute
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Orthostatic Hypotension Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Orthostatic Hypotension Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Orthostatic Hypotension Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orthostatic Hypotension Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Orthostatic Hypotension Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Midodrine
  1.4.3 Northera (droxidopa)
  1.4.4 Fludrocortisone
  1.4.5 Other Drugs
1.5 Market by Application
  1.5.1 Global Orthostatic Hypotension Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Medical Research Institute
  1.5.4 Clinic
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Orthostatic Hypotension Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Orthostatic Hypotension Drugs Industry
    1.6.1.1 Orthostatic Hypotension Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Orthostatic Hypotension Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Orthostatic Hypotension Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Orthostatic Hypotension Drugs Market Perspective (2015-2026)
2.2 Orthostatic Hypotension Drugs Growth Trends by Regions
  2.2.1 Orthostatic Hypotension Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Orthostatic Hypotension Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Orthostatic Hypotension Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Orthostatic Hypotension Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Orthostatic Hypotension Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Orthostatic Hypotension Drugs Players by Market Size
  3.1.1 Global Top Orthostatic Hypotension Drugs Players by Revenue (2015-2020)
  3.1.2 Global Orthostatic Hypotension Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Orthostatic Hypotension Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Orthostatic Hypotension Drugs Market Concentration Ratio
  3.2.1 Global Orthostatic Hypotension Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Orthostatic Hypotension Drugs Revenue in 2019
3.3 Orthostatic Hypotension Drugs Key Players Head office and Area Served
3.4 Key Players Orthostatic Hypotension Drugs Product Solution and Service
3.5 Date of Enter into Orthostatic Hypotension Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Orthostatic Hypotension Drugs Historic Market Size by Type (2015-2020)
4.2 Global Orthostatic Hypotension Drugs Forecasted Market Size by Type (2021-2026)

5 ORTHOSTATIC HYPOTENSION DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Orthostatic Hypotension Drugs Market Size by Application (2015-2020)
5.2 Global Orthostatic Hypotension Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Orthostatic Hypotension Drugs Market Size (2015-2020)
6.2 Orthostatic Hypotension Drugs Key Players in North America (2019-2020)
6.3 North America Orthostatic Hypotension Drugs Market Size by Type (2015-2020)
6.4 North America Orthostatic Hypotension Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Orthostatic Hypotension Drugs Market Size (2015-2020)
7.2 Orthostatic Hypotension Drugs Key Players in Europe (2019-2020)
7.3 Europe Orthostatic Hypotension Drugs Market Size by Type (2015-2020)
7.4 Europe Orthostatic Hypotension Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Orthostatic Hypotension Drugs Market Size (2015-2020)
8.2 Orthostatic Hypotension Drugs Key Players in China (2019-2020)
8.3 China Orthostatic Hypotension Drugs Market Size by Type (2015-2020)
8.4 China Orthostatic Hypotension Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Orthostatic Hypotension Drugs Market Size (2015-2020)
9.2 Orthostatic Hypotension Drugs Key Players in Japan (2019-2020)
9.3 Japan Orthostatic Hypotension Drugs Market Size by Type (2015-2020)
9.4 Japan Orthostatic Hypotension Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Orthostatic Hypotension Drugs Market Size (2015-2020)
10.2 Orthostatic Hypotension Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Orthostatic Hypotension Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Orthostatic Hypotension Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Orthostatic Hypotension Drugs Market Size (2015-2020)
11.2 Orthostatic Hypotension Drugs Key Players in India (2019-2020)
11.3 India Orthostatic Hypotension Drugs Market Size by Type (2015-2020)
11.4 India Orthostatic Hypotension Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Orthostatic Hypotension Drugs Market Size (2015-2020)
12.2 Orthostatic Hypotension Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Orthostatic Hypotension Drugs Market Size by Type (2015-2020)
12.4 Central & South America Orthostatic Hypotension Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Amneal Pharmaceuticals Inc.
  13.1.1 Amneal Pharmaceuticals Inc. Company Details
  13.1.2 Amneal Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.1.3 Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Introduction
  13.1.4 Amneal Pharmaceuticals Inc. Revenue in Orthostatic Hypotension Drugs Business (2015-2020))
  13.1.5 Amneal Pharmaceuticals Inc. Recent Development
13.2 H. Lundbeck AS
  13.2.1 H. Lundbeck AS Company Details
  13.2.2 H. Lundbeck AS Business Overview and Its Total Revenue
  13.2.3 H. Lundbeck AS Orthostatic Hypotension Drugs Introduction
  13.2.4 H. Lundbeck AS Revenue in Orthostatic Hypotension Drugs Business (2015-2020)
  13.2.5 H. Lundbeck AS Recent Development
13.3 Mylan NV
  13.3.1 Mylan NV Company Details
  13.3.2 Mylan NV Business Overview and Its Total Revenue
  13.3.3 Mylan NV Orthostatic Hypotension Drugs Introduction
  13.3.4 Mylan NV Revenue in Orthostatic Hypotension Drugs Business (2015-2020)
  13.3.5 Mylan NV Recent Development
13.4 Novartis AG
  13.4.1 Novartis AG Company Details
  13.4.2 Novartis AG Business Overview and Its Total Revenue
  13.4.3 Novartis AG Orthostatic Hypotension Drugs Introduction
  13.4.4 Novartis AG Revenue in Orthostatic Hypotension Drugs Business (2015-2020)
  13.4.5 Novartis AG Recent Development
13.5 Pfizer Inc.
  13.5.1 Pfizer Inc. Company Details
  13.5.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.5.3 Pfizer Inc. Orthostatic Hypotension Drugs Introduction
  13.5.4 Pfizer Inc. Revenue in Orthostatic Hypotension Drugs Business (2015-2020)
  13.5.5 Pfizer Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Orthostatic Hypotension Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Orthostatic Hypotension Drugs Revenue
Table 3. Ranking of Global Top Orthostatic Hypotension Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Orthostatic Hypotension Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Midodrine
Table 6. Key Players of Northera (droxidopa)
Table 7. Key Players of Fludrocortisone
Table 8. Key Players of Other Drugs
Table 9. COVID-19 Impact Global Market: (Four Orthostatic Hypotension Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Orthostatic Hypotension Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Orthostatic Hypotension Drugs Players to Combat Covid-19 Impact
Table 14. Global Orthostatic Hypotension Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Orthostatic Hypotension Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Orthostatic Hypotension Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Orthostatic Hypotension Drugs Market Share by Regions (2015-2020)
Table 18. Global Orthostatic Hypotension Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Orthostatic Hypotension Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Orthostatic Hypotension Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Orthostatic Hypotension Drugs Players
Table 25. Global Orthostatic Hypotension Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Orthostatic Hypotension Drugs Market Share by Players (2015-2020)
Table 27. Global Top Orthostatic Hypotension Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthostatic Hypotension Drugs as of 2019)
Table 28. Global Orthostatic Hypotension Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Orthostatic Hypotension Drugs Product Solution and Service
Table 31. Date of Enter into Orthostatic Hypotension Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Orthostatic Hypotension Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Orthostatic Hypotension Drugs Market Size Share by Type (2015-2020)
Table 35. Global Orthostatic Hypotension Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Orthostatic Hypotension Drugs Market Size Share by Application (2015-2020)
Table 37. Global Orthostatic Hypotension Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Orthostatic Hypotension Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Orthostatic Hypotension Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Orthostatic Hypotension Drugs Market Share (2019-2020)
Table 41. North America Orthostatic Hypotension Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Orthostatic Hypotension Drugs Market Share by Type (2015-2020)
Table 43. North America Orthostatic Hypotension Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Orthostatic Hypotension Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Orthostatic Hypotension Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Orthostatic Hypotension Drugs Market Share (2019-2020)
Table 47. Europe Orthostatic Hypotension Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Orthostatic Hypotension Drugs Market Share by Type (2015-2020)
Table 49. Europe Orthostatic Hypotension Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Orthostatic Hypotension Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Orthostatic Hypotension Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Orthostatic Hypotension Drugs Market Share (2019-2020)
Table 53. China Orthostatic Hypotension Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Orthostatic Hypotension Drugs Market Share by Type (2015-2020)
Table 55. China Orthostatic Hypotension Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Orthostatic Hypotension Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Orthostatic Hypotension Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Orthostatic Hypotension Drugs Market Share (2019-2020)
Table 59. Japan Orthostatic Hypotension Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Orthostatic Hypotension Drugs Market Share by Type (2015-2020)
Table 61. Japan Orthostatic Hypotension Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Orthostatic Hypotension Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Orthostatic Hypotension Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Orthostatic Hypotension Drugs Market Share (2019-2020)
Table 65. Southeast Asia Orthostatic Hypotension Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Orthostatic Hypotension Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Orthostatic Hypotension Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Orthostatic Hypotension Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Orthostatic Hypotension Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Orthostatic Hypotension Drugs Market Share (2019-2020)
Table 71. India Orthostatic Hypotension Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Orthostatic Hypotension Drugs Market Share by Type (2015-2020)
Table 73. India Orthostatic Hypotension Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Orthostatic Hypotension Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Orthostatic Hypotension Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Orthostatic Hypotension Drugs Market Share (2019-2020)
Table 77. Central & South America Orthostatic Hypotension Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Orthostatic Hypotension Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Orthostatic Hypotension Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Orthostatic Hypotension Drugs Market Share by Application (2015-2020)
Table 81. Amneal Pharmaceuticals Inc. Company Details
Table 82. Amneal Pharmaceuticals Inc. Business Overview
Table 83. Amneal Pharmaceuticals Inc. Product
Table 84. Amneal Pharmaceuticals Inc. Revenue in Orthostatic Hypotension Drugs Business (2015-2020) (Million US$)
Table 85. Amneal Pharmaceuticals Inc. Recent Development
Table 86. H. Lundbeck AS Company Details
Table 87. H. Lundbeck AS Business Overview
Table 88. H. Lundbeck AS Product
Table 89. H. Lundbeck AS Revenue in Orthostatic Hypotension Drugs Business (2015-2020) (Million US$)
Table 90. H. Lundbeck AS Recent Development
Table 91. Mylan NV Company Details
Table 92. Mylan NV Business Overview
Table 93. Mylan NV Product
Table 94. Mylan NV Revenue in Orthostatic Hypotension Drugs Business (2015-2020) (Million US$)
Table 95. Mylan NV Recent Development
Table 96. Novartis AG Company Details
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Product
Table 99. Novartis AG Revenue in Orthostatic Hypotension Drugs Business (2015-2020) (Million US$)
Table 100. Novartis AG Recent Development
Table 101. Pfizer Inc. Company Details
Table 102. Pfizer Inc. Business Overview
Table 103. Pfizer Inc. Product
Table 104. Pfizer Inc. Revenue in Orthostatic Hypotension Drugs Business (2015-2020) (Million US$)
Table 105. Pfizer Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Orthostatic Hypotension Drugs Market Share by Type: 2020 VS 2026
Figure 2. Midodrine Features
Figure 3. Northera (droxidopa) Features
Figure 4. Fludrocortisone Features
Figure 5. Other Drugs Features
Figure 6. Global Orthostatic Hypotension Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Medical Research Institute Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Orthostatic Hypotension Drugs Report Years Considered
Figure 12. Global Orthostatic Hypotension Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Orthostatic Hypotension Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Orthostatic Hypotension Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Orthostatic Hypotension Drugs Market Share by Players in 2019
Figure 17. Global Top Orthostatic Hypotension Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthostatic Hypotension Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Orthostatic Hypotension Drugs Revenue in 2019
Figure 19. North America Orthostatic Hypotension Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Orthostatic Hypotension Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Orthostatic Hypotension Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Orthostatic Hypotension Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Orthostatic Hypotension Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Orthostatic Hypotension Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Orthostatic Hypotension Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Amneal Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2015-2020)
Figure 28. H. Lundbeck AS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. H. Lundbeck AS Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2015-2020)
Figure 30. Mylan NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Mylan NV Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2015-2020)
Figure 32. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Novartis AG Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2015-2020)
Figure 34. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Inc. Revenue Growth Rate in Orthostatic Hypotension Drugs Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed